NDSI
ADAP
Newman Dignan & Sheerar Inc’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.7K | Hold |
27,957
| – | – | ﹤0.01% | 194 |
|
|
2025
Q1 | $5.51K | Hold |
27,957
| – | – | ﹤0.01% | 175 |
|
|
2024
Q4 | $15.1K | Hold |
27,957
| – | – | ﹤0.01% | 181 |
|
|
2024
Q3 | $20.6K | Buy |
+27,957
| New | +$20.6K | ﹤0.01% | 185 |
|
|
2024
Q1 | – | Sell |
-23,031
| Closed | -$18.3K | – | 172 |
|
|
2023
Q4 | $18.3K | Buy |
+23,031
| New | +$18.3K | 0.01% | 177 |
|
|
2023
Q3 | – | Sell |
-19,364
| Closed | -$17.9K | – | 166 |
|
|
2023
Q2 | $17.9K | Buy |
+19,364
| New | +$17.9K | 0.01% | 185 |
|